Effect of FTY720 and ICAM-1 mAb mono and combination therapy in cardiac allo-transplantation in rats

Abstract

Objective To observe the effect of FTY720 and ICAM-1 mAb mono and combination therapy in cardiac allo-transplantation in rats. Methods Rats were randomly assigned to 9 groups, heart allo-transplantation were performed in abdominal site with micro-surgical technique. Recipients with allografts were treated with different doses of FTY720 and (or) ICAM-1 mAb. Graft survival, histopathology and level of serum IL-2, IFN-γ, IL-4, IL-10 were investigated. Results Low doses of FTY720 (1mg/kg) combined with ICAM-1 mAb achieved synergistic effect in the prolongation of cardiac graft survival, combination index(CI)=0.67. Conclusion Concomitant therapy of FTY720 and ICAM-1 mAb achieved a synergistic effect in the prolongation of heart allograft survival in rats.

Keywords

FTY720 / ICAM-1 mAb / synergy / rat / heart transplantation / immune tolerance / rejection

References

[1] XiongHai-bo, WenHao. Comparison of rat allocardiac transplantation model in cervical and abdominal site [J]. Journal of XingJiang Medical University, 2003, 26(4): 355-357

[2] BillinghamM E, CaryN R, HammondM E, et al.. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group [J]. J Heart Transplant, 1990, 9(6): 587-593

[3] ChouT CChouT C, RideoutD. The median-effect principle and combination index for quantitation of synergism and antagonism[A]. Synergism and Antagonism in Chemotherapy[C], 1991, San Diego, Academic Press

[4] KimuraT, HasegawaT, NakaiH, et al.. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells [J]. Transplantation, 2003, 75(9): 1469-1474

[5] ChibaK, HoshinoY, OhtsukiM, et al.. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. prevention of allograft rejection inrats and dogs by FTY720 and FTY720-phosphate [J]. Transplant Proc, 2005, 37(1): 102-106

[6] PinschewerD D, OchsenbeinA F, OdermattB, et al.. FTY720 immunosuppression impairs effector T-cell peripheral homing without affecting induction, expansion, and memory [J]. J Immunol, 2000, 164(1): 5761-5770

[7] HoshinoY, YanagawaY, OhtsukiM, et al.. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK506 in rat allograft models[J]. Transplant Proc, 1999, 31(1–2): 1224-1226

[8] GrochowieckiT, GotohM, DonoK, et al.. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ICAM-1 pathway [J]. Transplantation, 2000, 69(8): 1567-1571

[9] IsobeM, YagitaH, OkumuraK, et al.. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1[J]. Science, 1992, 255(5048): 1125-1127

[10] PieterszG A, SandrinM S, LingS, et al.. LFA-1 and ICAM-1 antibody-idarubicin conjugates separately prolong murine cardiac allograft survival[J]. Transpl Immunol, 2001, 9(1): 7-11

[11] SaggiB H, FisherR A, BuD, et al.. Intra-graft cytokine expression and tolerance induction in rat renal allografts[J]. Transplantation, 1999, 67(2): 206-210